Arrowgrass Capital Partners (US)’s BioAmber Inc. BIOA.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-921,288
| Closed | -$40K | – | 670 |
|
|
2017
Q1 | $40K | Hold |
921,288
| – | – | ﹤0.01% | 569 |
|
|
2016
Q4 | $645K | Hold |
921,288
| – | – | 0.01% | 452 |
|
|
2016
Q3 | $435K | Hold |
921,288
| – | – | 0.01% | 405 |
|
|
2016
Q2 | $322K | Buy |
921,288
+1,100
| +0.1% | +$916 | ﹤0.01% | 389 |
|
|
2016
Q1 | $1.67M | Buy |
920,188
+168,409
| +22% | +$251K | 0.02% | 280 |
|
|
2015
Q4 | $530K | Hold |
751,779
| – | – | 0.01% | 355 |
|
|
2015
Q3 | $669K | Hold |
751,779
| – | – | 0.01% | 378 |
|
|
2015
Q2 | $741K | Buy |
751,779
+34,559
| +5% | +$67.9K | 0.01% | 432 |
|
|
2015
Q1 | $1.14M | Hold |
717,220
| – | – | 0.02% | 322 |
|
|
2014
Q4 | $1.58M | Hold |
717,220
| – | – | 0.03% | 262 |
|
|
2014
Q3 | $2.24M | Hold |
717,220
| – | – | 0.05% | 175 |
|
|
2014
Q2 | $2.27M | Buy |
717,220
+4,218
| +0.6% | +$9.59K | 0.07% | 124 |
|
|
2014
Q1 | $1.55M | Buy |
713,002
+5,200
| +0.7% | +$12.1K | 0.06% | 140 |
|
|
2013
Q4 | $517K | Hold |
707,802
| – | – | 0.02% | 146 |
|
|
2013
Q3 | $648K | Sell |
707,802
-43,498
| -6% | -$32.5K | 0.02% | 171 |
|
|
2013
Q2 | $7.51M | Buy |
+751,300
| New | +$477K | 0.77% | 32 |
|
Arrowgrass Capital Partners (US)'s BIOA.WS Position: Q2 2017 in Review
Arrowgrass Capital Partners (US) sold out of BioAmber Inc. (BIOA.WS) in Q2 2017, closing a stake of 921,288 shares — an estimated $40K sold.
Arrowgrass Capital Partners (US) first reported a position in BIOA.WS in Q2 2013 and held it in 16 quarters. The position peaked at $7.51M in Q2 2013. 0 funds tracked by Wall St. Rank hold BIOA.WS as of Q2 2017.
- Arrowgrass Capital Partners (US) reported no remaining BioAmber Inc. position as of Q2 2017 after selling out during the quarter.
- Arrowgrass Capital Partners (US) sold 921,288 BioAmber Inc. shares in Q2 2017, an estimated $40K.
- Arrowgrass Capital Partners (US) first reported a position in BioAmber Inc. in Q2 2013 and held it in 16 quarters.
- Arrowgrass Capital Partners (US)'s BioAmber Inc. position peaked at $7.51M in Q2 2013.
- 0 funds tracked by Wall St. Rank held BioAmber Inc. as of Q2 2017.
Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2017, filed 14 Aug 2017.